{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05716906",
            "orgStudyIdInfo": {
                "id": "2021P002832"
            },
            "organization": {
                "fullName": "Massachusetts General Hospital",
                "class": "OTHER"
            },
            "briefTitle": "Melatonin and Sleep Spindles in Autism",
            "officialTitle": "The Effects of Melatonin on Sleep Spindles in Children With Autism",
            "therapeuticArea": [
                "Other"
            ],
            "study": "melatonin-and-sleep-spindles-in-autism"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-01-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-01-30",
            "studyFirstSubmitQcDate": "2023-01-30",
            "studyFirstPostDateStruct": {
                "date": "2023-02-08",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-18",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-20",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Dara S. Manoach, PhD",
                "investigatorTitle": "Professor",
                "investigatorAffiliation": "Massachusetts General Hospital"
            },
            "leadSponsor": {
                "name": "Massachusetts General Hospital",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Sleep disturbances and sensory sensitivities are common disabling features of autism, but their underlying causes are not clear. We hypothesize that both of these difficulties reflect disrupted communication between a deep brain structure, the thalamus, and the brain's outer layer, the cortex. This communication is mediated by the thalamic reticular nucleus (TRN). Due to its small size and location deep in the brain, we cannot assess TRN function without invasive techniques. Fortunately, sleep spindles, a specific brain rhythm provide a noninvasive read-out of TRN function. In Aim 1 we will examine whether reduced sleep spindles are related to worse sleep quality, impaired selective attention during wake, and sensory sensitivities in children with autism. In Aim 2, we will determine whether melatonin, which is commonly used to improve sleep, also increases sleep spindles in autism. If successful, this study will introduce TRN as a target for treatment of sleep disruption and guide larger home-based sleep studies."
        },
        "conditionsModule": {
            "conditions": [
                "Autism Spectrum Disorder"
            ],
            "keywords": [
                "Melatonin"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Melatonin",
                    "type": "EXPERIMENTAL",
                    "description": "5mg melatonin gummy 30 min before bedtime for 2 consecutive nights",
                    "interventionNames": [
                        "Dietary Supplement: Melatonin"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Melatonin",
                    "description": "5mg gummy 30 min before bedtime for 2 consecutive nights",
                    "armGroupLabels": [
                        "Melatonin"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in sleep spindle density",
                    "description": "Changes in sleep spindle density (#/min) during non-Rapid Eye Movement (NREM) sleep between baseline and melatonin nights as measured by portable EEG device.",
                    "timeFrame": "Five nights of sleep over two weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in sleep quality",
                    "description": "Change in sleep quality between baseline and melatonin nights",
                    "timeFrame": "Five nights of sleep over two weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male and female subjects with ASD\n* 12-18 years of age\n* English speaking\n* Able to understand and respond to questionnaires in English\n\nExclusion Criteria:\n\n* Pregnant or breastfeeding\n* Substance abuse or dependence within the past six months (nicotine abuse or dependence is not exclusionary)\n* Chronic medical conditions that affect sleep\n* Any unstable chronic medical condition such as asthma, diabetes, cystic fibrosis, or cardiac disease\n* History of head injury resulting in prolonged loss of consciousness or other neurological sequelae\n* IQ \\<70\n* Other neurological disorder, including seizure disorder\n* Diagnosed sleep disorder\n* Known genetic causes of ASD\n* Currently taking melatonin or those who have had an adverse reaction to melatonin in the past",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "12 Years",
            "maximumAge": "18 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Dara Manoach, PhD",
                    "role": "CONTACT",
                    "phone": "617-724-6148",
                    "email": "manoachlab@gmail.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Dara Manoach, PhD",
                    "affiliation": "Professor",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Paige Townsend, PhD",
                            "role": "CONTACT",
                            "phone": "617-702-2368",
                            "email": "ptownsend2@mgh.harvard.edu"
                        },
                        {
                            "name": "Dimitrios Mylonas, PhD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "The PI will disseminate results through presentations at public lectures, scientific institutions and meetings, and/or publications in major journals. Specifically, quality-controlled data used in publications will be deidentified and made available to requesting scientists, after publication of the results. Workflows will be documented and will allow any external groups to reproduce results from the raw data.",
            "timeFrame": "Data will be available following the publication of the results."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001321",
                    "term": "Autistic Disorder"
                },
                {
                    "id": "D000067877",
                    "term": "Autism Spectrum Disorder"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002659",
                    "term": "Child Development Disorders, Pervasive"
                },
                {
                    "id": "D000065886",
                    "term": "Neurodevelopmental Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4623",
                    "name": "Autistic Disorder",
                    "asFound": "Autism",
                    "relevance": "HIGH"
                },
                {
                    "id": "M206",
                    "name": "Autism Spectrum Disorder",
                    "asFound": "Autism Spectrum Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5903",
                    "name": "Child Development Disorders, Pervasive",
                    "relevance": "LOW"
                },
                {
                    "id": "M5902",
                    "name": "Developmental Disabilities",
                    "relevance": "LOW"
                },
                {
                    "id": "M30644",
                    "name": "Neurodevelopmental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008550",
                    "term": "Melatonin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000975",
                    "term": "Antioxidants"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000020011",
                    "term": "Protective Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11533",
                    "name": "Melatonin",
                    "asFound": "Contrast",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4292",
                    "name": "Antioxidants",
                    "relevance": "LOW"
                },
                {
                    "id": "M21869",
                    "name": "Protective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "T410",
                    "name": "Melatonin",
                    "asFound": "Contrast",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Ot",
                    "name": "Other Dietary Supplements"
                }
            ]
        }
    },
    "hasResults": false
}